|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Amortization of financing costs | |||||
| Interest income, net | |||||
| Realized loss on investments, net | |||||
| Foreign exchange gain | |||||
| Realized gain on investments, net | |||||
| Total other income, net | |||||
| Net loss | |||||
| Other comprehensive loss, net of tax: | |||||
| Unrealized gain (loss) on securities | |||||
| Foreign currency translation gain (loss) | |||||
| Comprehensive loss | |||||
| Basic net loss per common share | |||||
| Weighted-average shares used to compute basic net loss per share | |||||
| Diluted net loss per common share | |||||
| Weighted-average shares used to compute diluted net loss per share | |||||
Loading...